Table 2.
Summary of baseline parameters
| Parameter | No. of patients | Median | Range | 1st Quartile | 3rd Quartile |
|---|---|---|---|---|---|
| LSR | 359 | 1.59 | 0.66 – 4.25 | 1.35 | 1.86 |
| Albumin (g/L) | 359 | 39.0 | 24.0 – 60.0 | 35.85 | 42.0 |
| Bilirubin (μmol/L) | 359 | 14.1 | 2.0 – 51.0 | 9.8 | 19.9 |
| INR | 321 | 1.1 | 0.63 – 4.34 | 1.0 | 1.2 |
| ALT (ukat/L) | 356 | 0.78 | 0.11 – 5.21 | 0.48 | 1.22 |
| AST (ukat/L) | 344 | 1.01 | 0.23 – 9.6 | 0.73 | 1.58 |
| GGT (ukat/L) | 355 | 3.55 | 0.16 – 41.1 | 1.85 | 6.7 |
| ALP (ukat/L) | 353 | 2.38 | 0.43 – 18.6 | 1.6 | 3.71 |
| Platelet count (×109/L) | 359 | 168 | 25 – 787 | 122.5 | 219.5 |
| Hemoglobin (g/dL) | 359 | 8.56 | 5.7 – 16.5 | 7.6 | 9.2 |
| Leukocytes (×109/L) | 359 | 6.4 | 0.52 – 17.5 | 5.0 | 7.97 |
| Total protein (g/L) | 345 | 75.7 | 60.6 – 98.0 | 71.0 | 80.0 |
| Creatinine (μmol/L) | 356 | 74.2 | 43.0 – 176.8 | 64.0 | 88.4 |
| BUN (mmol/L) | 310 | 5.35 | 0.74 – 22.8 | 4.1 | 7.45 |
| MELD-Na score | 321 | 8 | 6-23 | 7 | 9 |
| ALBI score | 359 | −2.57 | −4.13 to −1.30 | −2.90 | −2.19 |
ALBI, albumin-bilirubin; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; GGT, gamma-glutamyl transpeptidase; LSR, liver-to-spleen ratio; INR, international normalized ratio